The levels of Th2-associated cytokines (IL-4, IL-5, and IL-13) increased in various allergic asthma models; MSC treatments generally restored the Th1/Th2 balance and reduced the cytokine levels, as we also observed12,18,20,42,43. This evidence concerns the gene IL4 and allergic asthma.